{"log_id": 8099540556747525770, "direction": 0, "words_result_num": 54, "words_result": [{"probability": {"variance": 0.000159, "average": 0.98692, "min": 0.964629}, "location": {"width": 170, "top": 211, "height": 23, "left": 127}, "words": "使用时的特殊注意事项"}, {"probability": {"variance": 0.000565, "average": 0.982044, "min": 0.931727}, "location": {"width": 186, "top": 238, "height": 23, "left": 180}, "words": "不得使用含铝的注射材料"}, {"probability": {"variance": 0.03657, "average": 0.899262, "min": 0.426729}, "location": {"width": 134, "top": 269, "height": 21, "left": 178}, "words": "未经稀不得使用"}, {"probability": {"variance": 0.005845, "average": 0.966574, "min": 0.708766}, "location": {"width": 219, "top": 297, "height": 22, "left": 180}, "words": "不得用盐溶液配制或稀释本品"}, {"probability": {"variance": 0.014476, "average": 0.947904, "min": 0.402451}, "location": {"width": 822, "top": 317, "height": 33, "left": 185}, "words": "下要与其它任何药物混合或经同一个输液通道同时使用,(特别是5-尿嘧啶、碱性溶液、氮丁三醇、和含料氨"}, {"probability": {"variance": 0.028521, "average": 0.929499, "min": 0.433863}, "location": {"width": 171, "top": 356, "height": 21, "left": 195}, "words": "丁三醇的叶酸类药品"}, {"probability": {"variance": 0.00756, "average": 0.962716, "min": 0.665479}, "location": {"width": 237, "top": 383, "height": 23, "left": 179}, "words": "输注奥沙利铂后,需冲洗输液管"}, {"probability": {"variance": 0.008111, "average": 0.960526, "min": 0.681102}, "location": {"width": 193, "top": 413, "height": 21, "left": 180}, "words": "只能使用推荐的溶剂(见后)"}, {"probability": {"variance": 0.007787, "average": 0.976637, "min": 0.481056}, "location": {"width": 746, "top": 434, "height": 32, "left": 179}, "words": "如果配制的溶液中有任何沉淀物,都不能再使用,且应该按照法规要求对危险品的处理原则进行销毁"}, {"probability": {"variance": 0.02825, "average": 0.910852, "min": 0.574908}, "location": {"width": 79, "top": 471, "height": 23, "left": 130}, "words": "溶液的配制"}, {"probability": {"variance": 0.010315, "average": 0.961974, "min": 0.545336}, "location": {"width": 334, "top": 499, "height": 23, "left": 181}, "words": "配制溶液时应使用注射用水或5%预萄糖溶液"}, {"probability": {"variance": 0.014746, "average": 0.946059, "min": 0.467519}, "location": {"width": 454, "top": 524, "height": 30, "left": 180}, "words": "5mg包装需加入10mL溶剂,使奥沙利铂浓度达到5.0mg/mL"}, {"probability": {"variance": 0.02047, "average": 0.936194, "min": 0.465145}, "location": {"width": 431, "top": 555, "height": 25, "left": 209}, "words": "ng包装需加入20mL洛剂,使奥沙利铂浓度达到5.0m/ml"}, {"probability": {"variance": 0.007156, "average": 0.965889, "min": 0.658041}, "location": {"width": 504, "top": 581, "height": 29, "left": 179}, "words": "从微生物学和化学角度,配制的溶液必须立即用5%葡溶液稀释"}, {"probability": {"variance": 0.01454, "average": 0.952865, "min": 0.402674}, "location": {"width": 463, "top": 611, "height": 28, "left": 179}, "words": "使用前应检查其透明度,只有澄清的没有沉淀的液才能使用"}, {"probability": {"variance": 0.025021, "average": 0.924435, "min": 0.535189}, "location": {"width": 355, "top": 634, "height": 33, "left": 150}, "words": "本品为单次使用,任何剩余的溶液应丢掉"}, {"probability": {"variance": 0.001347, "average": 0.974184, "min": 0.902}, "location": {"width": 83, "top": 673, "height": 23, "left": 131}, "words": "注射前稀释"}, {"probability": {"variance": 0.01663, "average": 0.924716, "min": 0.577933}, "location": {"width": 584, "top": 694, "height": 35, "left": 119}, "words": "老从瓶中取配制的溶液,立即用25050ml的5%的葡萄糖溶波稀释成0"}, {"probability": {"variance": 0.004012, "average": 0.973794, "min": 0.754956}, "location": {"width": 238, "top": 693, "height": 22, "left": 765}, "words": "以上浓度的溶液,然后静咏输注"}, {"probability": {"variance": 0.007873, "average": 0.954089, "min": 0.656047}, "location": {"width": 295, "top": 728, "height": 25, "left": 163}, "words": "从微生物学角度看此溶液应立即使用"}, {"probability": {"variance": 0.008395, "average": 0.963239, "min": 0.55429}, "location": {"width": 853, "top": 751, "height": 34, "left": 161}, "words": "如果不立即使用,使用者必须保证使用前其贮的时间和条件、正常情况下在2℃到8°℃之间不应超过24小时,除"}, {"probability": {"variance": 0.014363, "average": 0.934365, "min": 0.631443}, "location": {"width": 301, "top": 789, "height": 23, "left": 138}, "words": "作稀释是在可控、肌认无菌的条件下进行"}, {"probability": {"variance": 0.005017, "average": 0.9707, "min": 0.712743}, "location": {"width": 443, "top": 815, "height": 30, "left": 166}, "words": "使用前应检查透明度,只有澄清而无沉淀的溶液才能使用"}, {"probability": {"variance": 0.001773, "average": 0.979128, "min": 0.846006}, "location": {"width": 327, "top": 847, "height": 26, "left": 166}, "words": "本品为单次使用,任何剩余的溶液应丢弃掉"}, {"probability": {"variance": 0.003108, "average": 0.955044, "min": 0.828864}, "location": {"width": 217, "top": 880, "height": 21, "left": 170}, "words": "不得用盐溶液配制和稀释本品"}, {"probability": {"variance": 0.002028, "average": 0.800738, "min": 0.755701}, "location": {"width": 36, "top": 911, "height": 23, "left": 135}, "words": "输注"}, {"probability": {"variance": 0.004284, "average": 0.969514, "min": 0.746787}, "location": {"width": 235, "top": 937, "height": 22, "left": 168}, "words": "奥沙利铂应用时不需要预先水化"}, {"probability": {"variance": 0.016981, "average": 0.942972, "min": 0.408968}, "location": {"width": 852, "top": 957, "height": 35, "left": 166}, "words": "奥沙利铂用250-500mL的5%的葡萄溶液稀释成0.2mg/mL以上浓度的溶液,必须通过外周或中央静脉注2-6小"}, {"probability": {"variance": 0.027097, "average": 0.729334, "min": 0.564723}, "location": {"width": 68, "top": 988, "height": 66, "left": 127}, "words": "的必"}, {"probability": {"variance": 0.019718, "average": 0.910714, "min": 0.484029}, "location": {"width": 501, "top": 1020, "height": 30, "left": 164}, "words": "当奥沙利铂与5氟尿嘧啶合用时,奥沙利铂应先于5-氟尿嘧啶使用"}, {"probability": {"variance": 0.060031, "average": 0.825608, "min": 0.371478}, "location": {"width": 86, "top": 1057, "height": 23, "left": 135}, "words": "弃物处理"}, {"probability": {"variance": 0.014036, "average": 0.94976, "min": 0.438897}, "location": {"width": 855, "top": 1074, "height": 34, "left": 165}, "words": "任何剩余药品,以及用于配制、稀和注射用的所有物品,必须按照细胞毒药物的标准医院程序和毒性废弃物处理"}, {"probability": {"variance": 6.9e-05, "average": 0.99285, "min": 0.973255}, "location": {"width": 181, "top": 1115, "height": 21, "left": 138}, "words": "的现行法律规定进行销毁"}, {"probability": {"variance": 6e-06, "average": 0.998228, "min": 0.992628}, "location": {"width": 92, "top": 1145, "height": 22, "left": 142}, "words": "【不良反应】"}, {"probability": {"variance": 0.015162, "average": 0.94359, "min": 0.509917}, "location": {"width": 851, "top": 1161, "height": 37, "left": 171}, "words": "奥沙利铂与5-氟尿嘧啶/亚叶酸联合使用期何,可观察到的最常见的不良反应为:胃肠道(腹泻,恶心,呕吐以及黏膜"}, {"probability": {"variance": 0.00361, "average": 0.9702, "min": 0.678685}, "location": {"width": 882, "top": 1192, "height": 36, "left": 138}, "words": "炎)、血液系统(中性粒细胞减少,血小板减少)以及神经系统反应(急性,量积性,外周感觉神经病变)。总体上,这些"}, {"probability": {"variance": 0.019523, "average": 0.9461, "min": 0.355632}, "location": {"width": 760, "top": 1224, "height": 33, "left": 137}, "words": "不良反应在奥沙利铂与5-尿嘧啶/亚叶酸联合使用时比单独使用5尿嘧啶/亚叶酸时更常见、更严重"}, {"probability": {"variance": 0.013495, "average": 0.917032, "min": 0.716732}, "location": {"width": 70, "top": 1264, "height": 21, "left": 172}, "words": "结直肠癌"}, {"probability": {"variance": 0.010218, "average": 0.945314, "min": 0.524131}, "location": {"width": 849, "top": 1282, "height": 35, "left": 171}, "words": "表1-3列出的不良反应发生率数据来自转移性结直肠癌治疗和结肠瘤辅助治疗的国外临床研究(奥沙利铂与5-氟尿唑"}, {"probability": {"variance": 0.006358, "average": 0.969208, "min": 0.626827}, "location": {"width": 511, "top": 1318, "height": 31, "left": 138}, "words": "啶/亚叶酸联合治疗组分别包括416和1108例患者),以及上市后经验"}, {"probability": {"variance": 0.003968, "average": 0.975993, "min": 0.63187}, "location": {"width": 842, "top": 1342, "height": 37, "left": 172}, "words": "表1中显示的不良反应发生率是采用下列标准定义的:很常见(≥10%),常见(≥1%且<10%),不常见(≥0.1%且<1%"}, {"probability": {"variance": 0.006349, "average": 0.955582, "min": 0.659394}, "location": {"width": 540, "top": 1377, "height": 33, "left": 138}, "words": "少见(≥0.01%且<0.1%)、极少见(<0.01%)、未知(无法从已知数据中评估)"}, {"probability": {"variance": 0.013478, "average": 0.960098, "min": 0.3756}, "location": {"width": 586, "top": 1403, "height": 33, "left": 305}, "words": "表1转移性结直肠治疗和结肠助治疗临床研究以及上市后不良反应总结"}, {"probability": {"variance": 0.000342, "average": 0.992241, "min": 0.929939}, "location": {"width": 222, "top": 1433, "height": 24, "left": 472}, "words": "根据系统器官分类的不良反应"}, {"probability": {"variance": 0, "average": 0.999808, "min": 0.999567}, "location": {"width": 57, "top": 1461, "height": 24, "left": 276}, "words": "很常见"}, {"probability": {"variance": 3e-06, "average": 0.998368, "min": 0.996781}, "location": {"width": 38, "top": 1459, "height": 20, "left": 512}, "words": "常见"}, {"probability": {"variance": 0.001263, "average": 0.97402, "min": 0.923769}, "location": {"width": 44, "top": 1455, "height": 22, "left": 691}, "words": "下常见"}, {"probability": {"variance": 1.6e-05, "average": 0.994456, "min": 0.990431}, "location": {"width": 39, "top": 1452, "height": 23, "left": 856}, "words": "少见"}, {"probability": {"variance": 0.032836, "average": 0.880105, "min": 0.489337}, "location": {"width": 105, "top": 1482, "height": 21, "left": 530}, "words": "给药部位情况"}, {"probability": {"variance": 0.005569, "average": 0.957301, "min": 0.794322}, "location": {"width": 110, "top": 1510, "height": 22, "left": 195}, "words": "注射部位反应"}, {"probability": {"variance": 0.015675, "average": 0.948453, "min": 0.506913}, "location": {"width": 759, "top": 1522, "height": 37, "left": 206}, "words": "渗漏也可能引起局部疼痛和炎症,后者可能很严重并引起包括坏痕在内的并发症,尤其是当奥沙利铂通"}, {"probability": {"variance": 0.003834, "average": 0.976265, "min": 0.697779}, "location": {"width": 583, "top": 1550, "height": 30, "left": 213}, "words": "过外周静脉途径输注时(见【注意事项】中“特殊警告和特殊使用注意事项”)"}, {"probability": {"variance": 0.009412, "average": 0.971592, "min": 0.482903}, "location": {"width": 456, "top": 1574, "height": 31, "left": 221}, "words": "已有报道沙射部位反应包括局部疼痛、发红、肿胀和血栓形成"}, {"probability": {"variance": 4e-06, "average": 0.998283, "min": 0.994682}, "location": {"width": 138, "top": 1602, "height": 21, "left": 516}, "words": "自主神经系统异常"}], "language": 3}